The effect of COPD exacerbation history on future exacerbation risk and mortality
Munn JS, Sutradhar R, Butler SJ, Fidler L, Blazer AJ, Vanfleteren L, Gershon AS. Ann Am Thorac Soc. 2026; 23(3): 379-389.
Publications
Hospitalization trends and risk factors in rheumatoid arthritis related interstitial lung disease: an observational study from Ontario, Canada
Fidler L, Munn J, Fisher JH, Shapera S, Gershon AS. Chest. 2025; S0012-3692(25)00680-4. Epub 2025 Jun 3.
Investigating use of diagnostic codes for post-COVID- 19 condition in Ontario health administrative data
Munn J, Atzema CL, Austin PC, Butler S, Fidler L, Wang X, Gershon AS. BMC Health Serv Res. 2025; 25(1):694. Epub 2025 May 14.
Early versus late onset interstitial lung disease in rheumatoid arthritis: an observational study of risk factors and mortality in Ontario, Canada
Fidler L, Widdifield J, Fisher J, Shapera S. Respirology. 2023; Dec 13 [Epub ahead of print].
Rheumatoid arthritis associated interstitial lung disease: trends in epidemiology and mortality in Ontario from 2000 to 2018
Fidler L, Widdifield J, Fisher JH, Shapera S, Gershon AS. Respir Med. 2023; May 12 [Epub ahead of print].
Ophthalmologic assessments in patients with newly diagnosed sarcoidosis: an observational study from a universal healthcare system
Fidler LM, Balter M, Fisher JH, To T, Kohly R, Gershon AS. Respir Med. 2021; 187:106575. Epub 2021 Aug 12.
Hospitalizations in sarcoidosis: a cohort study of a universal healthcare population
Fidler LM, Gershon A, Fisher JH, Stanbrook MB, To T, Balter M. Ann Am Thorac Soc. 2021; 18(11):1786-94. Epub 2021 Apr 8.
Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study
Fidler LM, Balter M, Fisher JH, To T, Stanbrook MB, Gershon A. Eur Respir J. 2019; 54(4):1900444. Epub 2019 Aug 7.